D. Xiong

发表

Synthesis of a Dual Functional Anti-MDR Tumor Agent PH II-7 with Elucidations of Anti-Tumor Effects and Mechanisms

Yun-hui Hu, Jianxiang Wang, T. Cheng, 2012, PloS one.

J. Li-Ling, D. Xiong, Jia-jing Wei, 2021, Journal of Ovarian Research.

Down-regulation of P-glycoprotein expression by sustained intracellular acidification in K562/Dox cells.

Jianxiang Wang, S. Wakabayashi, Li Ma, 2008, Biochemical and biophysical research communications.

Role of mammary epithelial and stromal P450 enzymes in the clearance and metabolic activation of 7,12-dimethylbenz(a)anthracene in mice.

Lihua Wang, B. Moorthy, Xinxin Ding, 2012, Toxicology letters.

AntiCD3Fv fused to human interleukin-3 deletion variant redirected T cells against human acute myeloid leukemic stem cells

Xiuli Zhang, Xiaolong Zhang, Ming Yang, 2015, Journal of Hematology & Oncology.

PHII-7 inhibits cell growth and induces apoptosis in leukemia cell line K562 as well as its MDR- counterpart K562/A02 through producing reactive oxygen species.

Yahui Ding, Ming Yang, D. Xiong, 2013, European journal of pharmacology.

Induced CD20 Expression on B-Cell Malignant Cells Heightened the Cytotoxic Activity of Chimeric Antigen Receptor Engineered T Cells.

Q. Rao, H. Xing, Z. Tian, 2019, Human gene therapy.

Mesenchymal stem cells deliver and release conditionally replicative adenovirus depending on hepatic differentiation to eliminate hepatocellular carcinoma cells specifically.

Xiaolong Zhang, Y. Ru, D. Xiong, 2016, Cancer letters.

Redirection of CD4+ and CD8+ T lymphocytes via an anti-CD3 × anti-CD19 bi-specific antibody combined with cytosine arabinoside and the efficient lysis of patient-derived B-ALL cells

Jianxiang Wang, Yan Yan, Xiaolong Zhang, 2015, Journal of Hematology & Oncology.

Bispecific CD3-HAC carried by E1A-engineered mesenchymal stromal cells against metastatic breast cancer by blocking PD-L1 and activating T cells

Jianxiang Wang, Xiaolong Zhang, M. Hao, 2019, Journal of Hematology & Oncology.

Sorcin silencing inhibits epithelial-to-mesenchymal transition and suppresses breast cancer metastasis in vivo

Yun-hui Hu, E. Yagüe, Ming Yang, 2013, Breast Cancer Research and Treatment.

Cytosine arabinoside promotes cytotoxic effect of T cells on leukemia cells mediated by bispecific antibody.

Jianxiang Wang, Yan Yan, Wei Li, 2013, Human gene therapy.

Mesenchymal stromal cells as vehicles of tetravalent bispecific Tandab (CD3/CD19) for the treatment of B cell lymphoma combined with IDO pathway inhibitor d-1-methyl-tryptophan

Xiaolong Zhang, D. Xiong, Leisheng Zhang, 2017, Journal of Hematology & Oncology.

The development of bispecific antibodies and their applications in tumor immune escape

Xiaolong Zhang, D. Xiong, D. Fan, 2017, Experimental Hematology & Oncology.

Improvement in soluble expression levels of a diabody by exchanging expression vectors.

Zhen-ping Zhu, Wenguo Jiang, Chun-zheng Yang, 2008, Protein expression and purification.

Specific coagulation markers may provide more therapeutic targets in COVID‐19 patients receiving prophylactic anticoagulant

Ziyong Sun, N. Tang, D. Xiong, 2020, Journal of Thrombosis and Haemostasis.

Fibrinolysis and COVID-19: A tale of two sites?

Ziyong Sun, N. Tang, D. Xiong, 2020 .

The protective role of neuregulin-1: A potential therapy for sepsis-induced cardiomyopathy.

Xi Wang, Xia Pan, Long Wang, 2016, European journal of pharmacology.

Sorcin, an important gene associated with multidrug-resistance in human leukemia cells.

Zhen-ping Zhu, Jing Qi, Chun-zheng Yang, 2006, Leukemia research.

Reactive oxygen species contribute to TRAIL receptors upregulation; the mechanism for PH II-7 augmenting TRAIL induced apoptosis in leukemia cells.

Shiwen Luo, D. Xiong, Hongwei Peng, 2015, European journal of pharmacology.

Anoikis induction and metastasis suppression by a new integrin αvβ3 inhibitor in human melanoma cell line M21

Hui Peng, Yongci Zhang, Ming Yang, 2011, Investigational New Drugs.

Inhibition of sorcin reverses multidrug resistance of K562/A02 cells and MCF-7/A02 cells via regulating apoptosis-related proteins

Jianxiang Wang, T. Cheng, Xin Cheng, 2013, Cancer Chemotherapy and Pharmacology.

A novel calmodulin antagonist O-(4-ethoxyl-butyl)-berbamine overcomes multidrug resistance in drug-resistant MCF-7/ADR breast carcinoma cells.

Rong Liu, Jing Qi, Chun-zheng Yang, 2010, Journal of pharmaceutical sciences.

The RNA/DNA‐binding protein PSF relocates to cell membrane and contributes cells' sensitivity to antitumor drug, doxorubicin

Qi Zhou, Hong Lu, Min Li, 2014, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

An Engineered Fusion Protein Anti-CD19(Fab)-LDM Effectively Inhibits ADR-Resistant B Cell Lymphoma

Y. Zhen, Ming Yang, D. Xiong, 2019, Front. Oncol..

A Novel Blockade CD47 Antibody With Therapeutic Potential for Cancer

Jianxiang Wang, M. Hao, D. Xiong, 2021, Frontiers in Oncology.

Efficient inhibition of human B-cell lymphoma xenografts with an anti-CD20 x anti-CD3 bispecific diabody.

Hui Peng, Zhen-ping Zhu, Min Yang, 2002, Cancer letters.

E1A-engineered human umbilical cord mesenchymal stem cells as carriers and amplifiers for adenovirus suppress hepatocarcinoma in mice

Zong-fang Li, Xiaolong Zhang, Hongbo R. Luo, 2016, Oncotarget.

Inhibition of human B-cell lymphoma by an anti-CD20 antibody and its chimeric F(ab')2 fragment via induction of apoptosis.

Hui Peng, Zhen-ping Zhu, Ming Yang, 2004, Cancer letters.

Efficacy of anti-CD20 chimeric Fab’ fragment on proliferation of B lymphoma cells

Hui Peng, Zhen-ping Zhu, Chun-zheng Yang, 2001 .

Growth hormone alleviates oxidative stress and improves the IVF outcomes of poor ovarian responders: a randomized controlled trial

D. Xiong, Jia-jing Wei, Yan Gong, 2020, Reproductive Biology and Endocrinology.

Growth hormone alleviates oxidative stress and improves IVF outcomes in Chinese women with poor ovarian response: A randomized controlled trial

D. Xiong, Jia-jing Wei, Yan Gong, 2020 .

Influence of the calmodulin antagonist EBB on cyclin B1 and Cdc2-p34 in human drug-resistant breast cancer MCF-7/ADR cells

Xu-Guang Shi, Yan-hong Cheng, Ming Yang, 2008 .

Co-expression of cytokeratin 8 and breast cancer resistant protein indicates a multifactorial drug-resistant phenotype in human breast cancer cell line.

Zhen-ping Zhu, Jing Qi, Chun-zheng Yang, 2008, Life sciences.

Antitumor effects of an engineered and energized fusion protein consisting of an anti-CD20 scFv fragment and lidamycin

Shenghua Zhang, Y. Zhen, Xin Cheng, 2011, Science China Life Sciences.

Down‐regulation of c‐fos by shRNA sensitizes adriamycin‐resistant MCF‐7/ADR cells to chemotherapeutic agents via P‐glycoprotein inhibition and apoptosis augmentation

Xiuli Zhang, D. Xiong, Hongwei Peng, 2013, Journal of cellular biochemistry.

The miR-106b∼25 cluster promotes bypass of doxorubicin-induced senescence and increase in motility and invasion by targeting the E-cadherin transcriptional activator EP300

S. Raguz, E. Yagüe, Y. Lombardo, 2013, Cell Death and Differentiation.

A novel indirubin derivative PHII-7 potentiates adriamycin cytotoxicity via inhibiting P-glycoprotein expression in human breast cancer MCF-7/ADR cells.

Rong Liu, Xiuli Zhang, Yin-liang Xie, 2011, European journal of pharmacology.

J. Li-Ling, D. Xiong, Jia-jing Wei, 2020, Journal of Ovarian Research.

Human umbilical cord mesenchymal stem cells as vehicles of CD20-specific TRAIL fusion protein delivery: a double-target therapy against non-Hodgkin's lymphoma.

Hongwei Peng, Dongsheng Xiong, Ming Yang, 2013, Molecular pharmaceutics.

Improvement of tumor targeting and antitumor activity by a disulphide bond stabilized diabody expressed in Escherichia coli

Ying-dai Gao, Yan Wang, Ming Yang, 2009, Cancer Immunology, Immunotherapy.

Up-regulated lncRNA XIST contributes to progression of cervical cancer via regulating miR-140-5p and ORC1

Lingfei Huang, D. Xiong, Liya Ye, 2019, Cancer Cell International.

Long noncoding RNA OPA‐interacting protein 5 antisense transcript 1 upregulated SMAD3 expression to contribute to metastasis of cervical cancer by sponging miR‐143‐3p

Lingfei Huang, D. Xiong, Liya Ye, 2018, Journal of cellular physiology.

Expression of ABCB5 gene in hematological malignances and its significance

Xiuli Zhang, Wei Li, Yan Yan, 2012, Leukemia & lymphoma.

Overexpression of sorcin in multidrug resistant human leukemia cells and its role in regulating cell apoptosis.

Ning Liu, Chunzheng Yang, Jing Qi, 2006, Biochemical and biophysical research communications.

Extracellular domain of 4-1BBL enhanced the antitumoral efficacy of peripheral blood lymphocytes mediated by anti-CD3 x anti-Pgp bispecific diabody against human multidrug-resistant leukemia.

Zhen-ping Zhu, Ying-dai Gao, Wenguo Jiang, 2008, Cellular immunology.

Efficient inhibition of multidrug-resistant human tumors with a recombinant bispecific anti-P-glycoprotein × anti-CD3 diabody

Z. Zhu, Y. Xu, L. Qin, 2004, Leukemia.

DDX43 promoter is frequently hypomethylated and may predict a favorable outcome in acute myeloid leukemia.

J. Qian, Jing Yang, Jiang Lin, 2014, Leukemia research.

The novel structure make LDM effectively remove CD123+ AML stem cells in combination with interleukin 3

J. Qian, Jianxiang Wang, Rong Liu, 2015, Cancer biology & therapy.

SPP1 inhibition improves the cisplatin chemo-sensitivity of cervical cancer cell lines

D. Xiong, Liya Ye, R. Mi, 2019, Cancer Chemotherapy and Pharmacology.

Lidamycin induces apoptosis of B-cell lymphoma cells and inhibits xenograft growth in nude mice

Y. Zhen, Qing-fang Miao, Hong Fang, 2009 .

Mesenchymal stem cells as delivery vectors for anti-tumor therapy.

D. Xiong, D. Fan, Zhen-zhen Li, 2015, Stem cell investigation.

Overexpression of cell surface cytokeratin 8 in multidrug-resistant MCF-7/MX cells enhances cell adhesion to the extracellular matrix.

Zhen-ping Zhu, Ziyou Cui, Chun-zheng Yang, 2008, Neoplasia.

Overexpression of Cell Surface Cytokeratin 8 in

Zhen-ping Zhu, Ziyou Cui, Chun-zheng Yang, 2008 .

Efficient Inhibition of Human B-cell Lymphoma in SCID Mice by Synergistic Antitumor Effect of Human 4-1BB Ligand/Anti-CD20 Fusion Proteins and Anti-CD3/Anti-CD20 Diabodies

Zhen-ping Zhu, Rong Liu, Wenguo Jiang, 2010, Journal of immunotherapy.

Up-regulated lncRNA XIST contributes to progression of cervical cancer via regulating miR-140-5p and ORC1

Lingfei Huang, D. Xiong, Liya Ye, 2019, Cancer Cell International.

A novel antibody–drug conjugate anti-CD19(Fab)-LDM in the treatment of B-cell non-Hodgkin lymphoma xenografts with enhanced anticancer activity

Y. Zhen, Ming Yang, Yuan Zhou, 2016, Journal of drug targeting.

Discovery and characterization of potent pan-variant SARS-CoV-2 neutralizing antibodies from individuals with Omicron breakthrough infection

Z. Rao, Ping Zhu, Jiaxi Zhou, 2023, Nature communications.

J. Li-Ling, D. Xiong, Jia-jing Wei, 2020 .

A Novel CD3/BCMA Bispecific T-cell Redirecting Antibody for the Treatment of Multiple Myeloma

Jianxiang Wang, Xiaomin Lei, Xiaolong Zhang, 2021, Journal of immunotherapy.

Systemic administration of mesenchymal stem cells loaded with a novel oncolytic adenovirus carrying a bispecific T cell engager against hepatocellular carcinoma

D. Xiong, Lei Yang, Yang Lu, 2023, Oncoimmunology.

Suppression of orthotopically implanted hepatocarcinoma in mice by umbilical cord-derived mesenchymal stem cells with sTRAIL gene expression driven by AFP promoter.

Jianxiang Wang, Ming Yang, D. Xiong, 2014, Biomaterials.